Molecular therapy for DM: Angiopoietin-like protein 1 promotes insulin resistance via up regulation of its target gene, 22/October/2014, 19.59

Molecular therapy for DM: Angiopoietin-like protein 1 promotes insulin resistance via up regulation of its target gene, 22/October/2014, 19.59

Molecular therapy for DM: Angiopoietin-like protein 1 promotes insulin resistance via up regulation of its target gene, 22/October/2014, 19.59 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, L., Molecular therapy for DM: Angiopoietin-like protein 1  promotes insulin resistance via up regulation of its target gene, 22/October/2014, 19.59, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Significance: This study suggests that Angiopoietin-like protein 1, by increasing the expression of its target gene, it may promote insulin sensitivity Thus, pharmacological formulations encompassing Angiopoietin-like protein 1 suppressors may be used to increase insulin sensitivity.

Amount: $300

Undisclosed information: A detailed mechanistic insight into how  Angiopoietin-like protein 1 promotes insulin resistance.

Courtesy: When you cite drop us a line at info@genomediscovery.org

Web: http://genomediscovery.org